D-Index & Metrics Best Publications
Immunology
Italy
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 97 Citations 34,190 396 World Ranking 480 National Ranking 13
Medicine D-index 100 Citations 35,812 444 World Ranking 4931 National Ranking 139

Research.com Recognitions

Awards & Achievements

2022 - Research.com Immunology in Italy Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Immune system

Giorgio Parmiani spends much of his time researching Immunology, Antigen, Cytotoxic T cell, Cancer research and Melanoma. His Immunotherapy, T cell, T lymphocyte, Immune system and Antigen-presenting cell investigations are all subjects of Immunology research. His Antigen research includes themes of Human tumor, Antigen presentation and Cell biology.

His work deals with themes such as Epitope and Molecular biology, which intersect with Cytotoxic T cell. His studies deal with areas such as Cancer stem cell, Haematopoiesis and Cell culture, Epithelial cell adhesion molecule as well as Cancer research. His Melanoma research integrates issues from In vitro, Mutation, Gene, Metastasis and Peptide.

His most cited work include:

  • Phenotypic characterization of human colorectal cancer stem cells (1759 citations)
  • A listing of human tumor antigens recognized by T cells. (800 citations)
  • Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 (772 citations)

What are the main themes of his work throughout his whole career to date?

Giorgio Parmiani mainly investigates Immunology, Antigen, Melanoma, Molecular biology and Cytotoxic T cell. His work focuses on many connections between Immunology and other disciplines, such as Cancer research, that overlap with his field of interest in Cytokine. His research investigates the connection between Antigen and topics such as Transplantation that intersect with issues in Neoplasm and Fibrosarcoma.

Giorgio Parmiani focuses mostly in the field of Melanoma, narrowing it down to topics relating to Oncology and, in certain cases, Metastatic melanoma. Giorgio Parmiani focuses mostly in the field of Molecular biology, narrowing it down to matters related to In vitro and, in some cases, In vivo. His research in Cytotoxic T cell tackles topics such as T-cell receptor which are related to areas like T lymphocyte.

He most often published in these fields:

  • Immunology (52.91%)
  • Antigen (35.43%)
  • Melanoma (29.37%)

What were the highlights of his more recent work (between 2006-2018)?

  • Immunology (52.91%)
  • Antigen (35.43%)
  • Immunotherapy (20.85%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Immunology, Antigen, Immunotherapy, Cancer and Immune system. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Cancer research, Melanoma. His Cancer research research incorporates themes from Cancer cell and Cancer stem cell.

His biological study spans a wide range of topics, including Lymphocyte and Immunogenicity. The various areas that Giorgio Parmiani examines in his Cancer study include Clinical trial and Family medicine. His work carried out in the field of Immune system brings together such families of science as Adjuvant and Antibody.

Between 2006 and 2018, his most popular works were:

  • Phenotypic characterization of human colorectal cancer stem cells (1759 citations)
  • Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine (574 citations)
  • Therapeutic vaccines for cancer: an overview of clinical trials (432 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

His main research concerns Immunology, Immunotherapy, Cancer, Antigen and Immune system. Giorgio Parmiani interconnects Cancer research, Clinical trial, CD44, Cancer stem cell and Cytotoxic T cell in the investigation of issues within Immunology. His Immunotherapy research is multidisciplinary, incorporating elements of Neo epitope and Clinical success.

His Cancer research includes elements of Melanoma and Oncology. The concepts of his Antigen study are interwoven with issues in Monocyte differentiation, Angiogenesis and Vaccination. His study in the field of T cell and Immunization is also linked to topics like Circulating microvesicle.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Phenotypic characterization of human colorectal cancer stem cells

Piero Dalerba;Scott J. Dylla;In Kyung Park;Rui Liu.
Proceedings of the National Academy of Sciences of the United States of America (2007)

2574 Citations

A listing of human tumor antigens recognized by T cells.

Nicolina Renkvist;Chiara Castelli;Paul F. Robbins;Giorgio Parmiani.
Cancer Immunology, Immunotherapy (2001)

1257 Citations

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

M Marchand;N van Baren;N van Baren;P Weynants;P Weynants;V Brichard;V Brichard;V Brichard.
International Journal of Cancer (1999)

1084 Citations

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

Paola Filipazzi;Roberta Valenti;Veronica Huber;Lorenzo Pilla.
Journal of Clinical Oncology (2007)

915 Citations

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

Giovanna Andreola;Licia Rivoltini;Chiara Castelli;Veronica Huber.
Journal of Experimental Medicine (2002)

857 Citations

Therapeutic vaccines for cancer: an overview of clinical trials

Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber.
Nature Reviews Clinical Oncology (2014)

709 Citations

A listing of human tumor antigens recognized by T cells: March 2004 update

Luisa Novellino;Chiara Castelli;Giorgio Parmiani.
Cancer Immunology, Immunotherapy (2005)

658 Citations

Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes

Roberta Valenti;Veronica Huber;Paola Filipazzi;Lorenzo Pilla.
Cancer Research (2006)

573 Citations

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

M Marchand;P Weynants;E Rankin;F Arienti.
International Journal of Cancer (1995)

560 Citations

Tumor-Released Microvesicles as Vehicles of Immunosuppression

Roberta Valenti;Veronica Huber;Manuela Iero;Paola Filipazzi.
Cancer Research (2007)

555 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Giorgio Parmiani

Thierry Boon

Thierry Boon

Ludwig Cancer Research

Publications: 114

Soldano Ferrone

Soldano Ferrone

Harvard University

Publications: 106

Francesco M. Marincola

Francesco M. Marincola

National Institutes of Health

Publications: 95

Stefano Fais

Stefano Fais

Istituto Superiore di Sanità

Publications: 86

Theresa L. Whiteside

Theresa L. Whiteside

University of Pittsburgh

Publications: 85

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 85

Kyogo Itoh

Kyogo Itoh

Kurume University

Publications: 79

Pierre Coulie

Pierre Coulie

Université Catholique de Louvain

Publications: 72

Mario P. Colombo

Mario P. Colombo

University of Milan

Publications: 72

Daniel E. Speiser

Daniel E. Speiser

University of Lausanne

Publications: 68

Licia Rivoltini

Licia Rivoltini

Fondazione IRCCS Istituto Nazionale dei Tumori

Publications: 67

Pedro Romero

Pedro Romero

University of Lausanne

Publications: 66

Giulio C. Spagnoli

Giulio C. Spagnoli

University Hospital of Basel

Publications: 60

Per thor Straten

Per thor Straten

University of Copenhagen

Publications: 56

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 56

Michele Maio

Michele Maio

University of Siena

Publications: 54

Trending Scientists

Anna Vilanova

Anna Vilanova

Eindhoven University of Technology

Heikki Tenhu

Heikki Tenhu

University of Helsinki

Tomitake Tsukihara

Tomitake Tsukihara

University of Hyogo

J. M. De Teresa

J. M. De Teresa

Spanish National Research Council

Haitao Huang

Haitao Huang

Hong Kong Polytechnic University

Kinji Ohno

Kinji Ohno

Nagoya University

Matthew Berriman

Matthew Berriman

Wellcome Sanger Institute

Christopher C. Mundt

Christopher C. Mundt

Oregon State University

Michael Granato

Michael Granato

University of Pennsylvania

Noel W. Davies

Noel W. Davies

University of Leicester

Andrew W. Murray

Andrew W. Murray

Flinders University

Victor Nussenzweig

Victor Nussenzweig

New York University

J. B. Blake

J. B. Blake

The Aerospace Corporation

Christophe Caux

Christophe Caux

Grenoble Alpes University

Brandon J. Schmeichel

Brandon J. Schmeichel

Texas A&M University

Andrzej Nowak

Andrzej Nowak

University of Warsaw

Something went wrong. Please try again later.